| Bayla Mandel, | |
|
7035 150th St, Flushing, NY 11367-2024 | |
| (718) 263-4004 | |
| Not Available |
| Full Name | Bayla Mandel |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7035 150th St, Flushing, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033652706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 015750-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bayla Mandel, 7035 150th St, Flushing, NY 11367-2024 Ph: (718) 263-4004 | Bayla Mandel, 7035 150th St, Flushing, NY 11367-2024 Ph: (718) 263-4004 |
News Archive
Fat tissue shows a robust circadian rhythm in a dish.In humans, glucose tolerance varies with time of day, but the mechanism responsible for the variation in insulin sensitivity throughout the day is unclear.
Researchers from Carnegie Mellon University's Computational Biology Department in the School of Computer Science have developed a new process that could reinvigorate the search for natural product drugs to treat cancers, viral infections and other ailments.
After months of hearings and negotiations, millions of dollars in attack ads, full-court press lobbying efforts and countless rounds of negotiations, Congress appeared to be moving toward a solution to the nation's surprise medical bill problem. Sort of.
Preliminary data published in the BMJ suggest that folate supplementation during pregnancy may increase a mother's long-term risk of breast cancer. Although this may be a chance finding, the results require confirmation, say the authors.
Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced a collaboration with Kadmon Corporation, LLC, to explore the utility of Biodesix' VeriStrat® test in a Phase 3 non-small cell lung cancer (NSCLC) study of Kadmon's KD019, a reversible tyrosine kinase inhibitor (TKI) targeting EGFR, HER2, VEGFR2 & 3, and SRC.
› Verified 9 days ago
Hamutal Davidov, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14730 73rd Ave, Flushing, NY 11367 Phone: 347-617-9578 | |
Elanna Osdoby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2966 137th St, Flushing, NY 11354 Phone: 718-445-2902 | |
Sungkuk Park, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4320 Murray St Fl 2, Flushing, NY 11355 Phone: 718-578-8708 | |
Michele Gamzo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3474 113th St, Flushing, NY 11368 Phone: 718-429-5700 | |
Shoma Johnson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3506 169th St Apt C1, Flushing, NY 11358 Phone: 678-622-1933 | |
Lee Anne Robison, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1651 Fax: 516-437-4167 | |
Ms. Jean Ng Pack, MA, CCC-SLP, TSHH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16327 26th Ave, Flushing, NY 11358 Phone: 917-952-3134 |